Back to Search Start Over

The time-of-day of myocardial infarction onset affects healing through oscillations in cardiac neutrophil recruitment

Authors :
Maximilian J. Schloss
Michael Horckmans
Maik Drechsler
Johan Duchene
Sabine Steffens
Katrin Nitz
Kiril Bidzhekov
Christian Weber
Oliver Soehnlein
Christoph Scheiermann
Biochemie
RS: CARIM - R3.07 - Structure-function analysis of the chemokine interactome for therapeutic targeting and imaging in atherosclerosis
Pathologie
RS: CARIM - R1.01 - Blood proteins & engineering
Pathology
Source :
EMBO molecular medicine, 8 (8, EMBO Molecular Medicine, EMBO Molecular Medicine, Vol. 8, No 8 (2016) pp. 937-48, EMBO Molecular Medicine, 8(8), 937-948. Wiley-Blackwell, EMBO molecular medicine, 8(8), 937-948. Wiley-Blackwell
Publication Year :
2016

Abstract

Myocardial infarction (MI) is the leading cause of death in Western countries. Epidemiological studies show acute MI to be more prevalent in the morning and to be associated with a poorer outcome in terms of mortality and recovery. The mechanisms behind this association are not fully understood. Here, we report that circadian oscillations of neutrophil recruitment to the heart determine infarct size, healing, and cardiac function after MI Preferential cardiac neutrophil recruitment during the active phase (Zeitgeber time, ZT13) was paralleled by enhanced myeloid progenitor production, increased circulating numbers of CXCR2(hi) neutrophils as well as upregulated cardiac adhesion molecule and chemokine expression. MI at ZT13 resulted in significantly higher cardiac neutrophil infiltration compared to ZT5, which was inhibited by CXCR2 antagonism or neutrophil-specific CXCR2 knockout. Limiting exaggerated neutrophilic inflammation at this time point significantly reduced the infarct size and improved cardiac function.<br />info:eu-repo/semantics/published

Details

Language :
English
ISSN :
17574676 and 17574684
Database :
OpenAIRE
Journal :
EMBO molecular medicine, 8 (8, EMBO Molecular Medicine, EMBO Molecular Medicine, Vol. 8, No 8 (2016) pp. 937-48, EMBO Molecular Medicine, 8(8), 937-948. Wiley-Blackwell, EMBO molecular medicine, 8(8), 937-948. Wiley-Blackwell
Accession number :
edsair.doi.dedup.....97098bb226dc7068f13e1d7dc1021fc5